Structure–function insights reveal the human ribosome as a cancer target for antibiotics

Citations Over TimeTop 10% of 2016 papers

Abstract

Many antibiotics in clinical use target the bacterial ribosome by interfering with the protein synthesis machinery. However, targeting the human ribosome in the case of protein synthesis deregulations such as in highly proliferating cancer cells has not been investigated at the molecular level up to now. Here we report the structure of the human 80S ribosome with a eukaryote-specific antibiotic and show its anti-proliferative effect on several cancer cell lines. The structure provides insights into the detailed interactions in a ligand-binding pocket of the human ribosome that are required for structure-assisted drug design. Furthermore, anti-proliferative dose response in leukaemic cells and interference with synthesis of c-myc and mcl-1 short-lived protein markers reveals specificity of a series of eukaryote-specific antibiotics towards cytosolic rather than mitochondrial ribosomes, uncovering the human ribosome as a promising cancer target.

Related Papers

• → Mass spectrometric analysis of the human 40S ribosomal subunit: Native and HCV IRES‐bound complexes(2005)101 cited
• → IRES-induced conformational changes in the ribosome and the mechanism of translation initiation by internal ribosomal entry(2009)88 cited
• → Attenuation of 40S Ribosomal Subunit Abundance Differentially Affects Host and HCV Translation and Suppresses HCV Replication(2012)51 cited
• → LOOP IIId of the HCV IRES is essential for the structural rearrangement of the 40S-HCV IRES complex(2015)40 cited
• Hepatitis C Virus IRES RNA—Induced Changes in the Conformation of the 40S(2001)